Hypertension is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Also referred to as arterial hypertension or high blood pressure in generic terms, the condition is measured in terms of systolic and diastolic pressure. At rest blood pressure level is in the range of 120-140 mm Hg systolic and 60-90mm Hg diastolic. Hypertension arises when it is persistently at or above the 140/90mm Hg level. Primary hypertension, a condition with no underlying medical cause is highly prevalent than secondary hypertension which is caused by other conditions such as kidney, heart, endocrine or arterial disorders. Changing lifestyle habits such as diet, smoking and exercising are the major cause of hypertension. Hypertension is one of the most powerful risk factors for cardiovascular morbidity and mortality.
Browse Complete report with TOC :
http://www.marketresearchreports.biz/analysis-details/anti-hypertensive-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Based on their therapeutic class, the anti-hypertensive drugs market is classified into diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, beta blockers, alpha blockers, vasodilators and renin inhibitors. These drugs find their therapeutic use as single drug administration or in fixed dose combinations. Diuretics are the first line of treatment recommended by the physicians for most patients. However, the drug preference depends on the patient’s medical history and current conditions. For instance, a hypertensive patient with diabetes may be recommended an ACE inhibitor as a first line treatment.
Hypertension is a lifelong disease, which means that a patient may require to take medications every day for the rest of his/her life. Thus, the demand for anti-hypertensive dugs is sustainable and will increase with increase in the number of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the global sales value of more than USD 40 billion, according to the World Preview 2018 report by Evaluate Pharma.
This market however, will be volatile due to patent expiries of blockbuster drugs, generic erosion, and launch of novel molecules. For example, the patent expiration of blockbuster drugs such as Diovan, Revatio, Avapro, Exforge and BIopress has impacted the global anti-hypertensive market with the entry of generics. On the other hand, the demand for fixed dose combinations is certain to rise, backed by the increase in number of patients. Factors such as aging population and lifestyle modifications will lead to an increase in the global incidence rate of hypertension.
Some of the key players contributing to the global anti-hypertensive drugs market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Takeda Pharmaceutical Company Limited.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
• North America
• Asia Pacific
• Europe
• Rest of the World
This report provides comprehensive analysis of
• Market growth drivers
• Factors limiting market growth
• Current market trends
• Market structure
• Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
To Download Sample Report Visit @
http://www.marketresearchreports.biz/sample/toc/186947
Reasons for Buying this Report
• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified SWOT analysis of major market segments
Latest Report:
Building and Construction Plastics Market (PVC, PS, Acrylics, PU, TPE, Composite Materials and Others) For Pipes & Ducts, Insulation, Door Fittingsand Other Applications: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
: http://www.marketresearchreports.biz/analysis-details/building-and-construction-plastics-market-pvc-ps-acrylics-pu-tpe-composite-materials-and-others-for-pipes-and-ducts-insulation-door-fittingsand-other-applications-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The report covers forecast and analysis for the building & construction plastics market on a global and regional level. The study provides historical data of 2012 along with a forecast from 2013 to 2019 based on both volumes (kilo tons) and revenue (USD million). The study includes drivers and restraints for the building & construction plastics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the building & construction plastics market on a global and regional level.
In order to give the users of this report a comprehensive view on the building & construction plastics Market, we have included a detailed value chain analysis. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the building & construction plastics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate, general attractiveness and company market share.
The study provides a decisive view on the building & construction plastics market by segmenting the market based on product types and applications. All the product and application segments have been analyzed based on present and future trends and the CAGR for the market is estimated between2013 and2019. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific and Rest of the World (RoW). This segmentation includes demand for individual applications in all the regions.
To Download Sample : http://www.marketresearchreports.biz/sample/sample/186977
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BASF SE, Borealis AG, DuPont, The Dow Chemical Company, Solvay SA, Arkema SA and PetroChina Ltd. among others. Company profiles include attributes such as company overview, financial overview, business strategy, SWOT analysis and recent developments. The market has been segmented as below:
Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
: http://www.marketresearchreports.biz/analysis-details/endocrine-testing-market-e2-fsh-hcg-lh-dheas-progesterone-testosterone-tsh-prolactin-cortisol-insulin-tests-and-others--global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests.
The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices.
To Download Sample : http://www.marketresearchreports.biz/sample/sample/186981
On the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Africa, Latin America and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the endocrine testing market and future opportunities are provided in the report. A PESTLE analysis has also been considered while estimating the market for individual geographies in order to provide current as well as future status. Several other analytical perspectives such as Porter’s Five Forces Analysis, market share analysis and market attractiveness have been described in the report in order to give a thorough analysis of the market. Also, a list of recommendations for existing as well as new entrants has also been discussed in the study which would help in decision making.
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
Site: http://www.marketresearchreports.biz/
Blog: Market Research Articles
Browse Complete report with TOC :
http://www.marketresearchreports.biz/analysis-details/anti-hypertensive-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Based on their therapeutic class, the anti-hypertensive drugs market is classified into diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, beta blockers, alpha blockers, vasodilators and renin inhibitors. These drugs find their therapeutic use as single drug administration or in fixed dose combinations. Diuretics are the first line of treatment recommended by the physicians for most patients. However, the drug preference depends on the patient’s medical history and current conditions. For instance, a hypertensive patient with diabetes may be recommended an ACE inhibitor as a first line treatment.
Hypertension is a lifelong disease, which means that a patient may require to take medications every day for the rest of his/her life. Thus, the demand for anti-hypertensive dugs is sustainable and will increase with increase in the number of target patients. Anti-hypertensive drugs were the second largest therapy area in 2011 with the global sales value of more than USD 40 billion, according to the World Preview 2018 report by Evaluate Pharma.
This market however, will be volatile due to patent expiries of blockbuster drugs, generic erosion, and launch of novel molecules. For example, the patent expiration of blockbuster drugs such as Diovan, Revatio, Avapro, Exforge and BIopress has impacted the global anti-hypertensive market with the entry of generics. On the other hand, the demand for fixed dose combinations is certain to rise, backed by the increase in number of patients. Factors such as aging population and lifestyle modifications will lead to an increase in the global incidence rate of hypertension.
Some of the key players contributing to the global anti-hypertensive drugs market include Novartis AG, Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Takeda Pharmaceutical Company Limited.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
• North America
• Asia Pacific
• Europe
• Rest of the World
This report provides comprehensive analysis of
• Market growth drivers
• Factors limiting market growth
• Current market trends
• Market structure
• Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
To Download Sample Report Visit @
http://www.marketresearchreports.biz/sample/toc/186947
Reasons for Buying this Report
• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified SWOT analysis of major market segments
Latest Report:
Building and Construction Plastics Market (PVC, PS, Acrylics, PU, TPE, Composite Materials and Others) For Pipes & Ducts, Insulation, Door Fittingsand Other Applications: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
: http://www.marketresearchreports.biz/analysis-details/building-and-construction-plastics-market-pvc-ps-acrylics-pu-tpe-composite-materials-and-others-for-pipes-and-ducts-insulation-door-fittingsand-other-applications-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The report covers forecast and analysis for the building & construction plastics market on a global and regional level. The study provides historical data of 2012 along with a forecast from 2013 to 2019 based on both volumes (kilo tons) and revenue (USD million). The study includes drivers and restraints for the building & construction plastics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the building & construction plastics market on a global and regional level.
In order to give the users of this report a comprehensive view on the building & construction plastics Market, we have included a detailed value chain analysis. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the building & construction plastics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate, general attractiveness and company market share.
The study provides a decisive view on the building & construction plastics market by segmenting the market based on product types and applications. All the product and application segments have been analyzed based on present and future trends and the CAGR for the market is estimated between2013 and2019. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific and Rest of the World (RoW). This segmentation includes demand for individual applications in all the regions.
To Download Sample : http://www.marketresearchreports.biz/sample/sample/186977
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BASF SE, Borealis AG, DuPont, The Dow Chemical Company, Solvay SA, Arkema SA and PetroChina Ltd. among others. Company profiles include attributes such as company overview, financial overview, business strategy, SWOT analysis and recent developments. The market has been segmented as below:
Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
: http://www.marketresearchreports.biz/analysis-details/endocrine-testing-market-e2-fsh-hcg-lh-dheas-progesterone-testosterone-tsh-prolactin-cortisol-insulin-tests-and-others--global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests.
The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices.
To Download Sample : http://www.marketresearchreports.biz/sample/sample/186981
On the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Africa, Latin America and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the endocrine testing market and future opportunities are provided in the report. A PESTLE analysis has also been considered while estimating the market for individual geographies in order to provide current as well as future status. Several other analytical perspectives such as Porter’s Five Forces Analysis, market share analysis and market attractiveness have been described in the report in order to give a thorough analysis of the market. Also, a list of recommendations for existing as well as new entrants has also been discussed in the study which would help in decision making.
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
Site: http://www.marketresearchreports.biz/
Blog: Market Research Articles
